Interstitial Lung Disease (ILD) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Interstitial Lung Disease (ILD) Market is estimated to be valued at US$ 1578.9 million in 2021 and is expected to exhibit a CAGR of 6% during the forecast period (2022-2028).

Interstitial lung disease (ILD) is a term used for a group of disorders that cause scarring (fibrosis) in the lungs. These scars cause stiffness in the lungs, making breathing difficult and bringing oxygen to the bloodstream. Interstitial lung disease can be caused by prolonged exposure to harmful substances such as asbestos. Some types of autoimmune diseases, such as rheumatoid arthritis, can also cause interstitial lung disease. Diseases classified as interstitial lung diseases are interstitial pneumonia, idiopathic pulmonary fibrosis, non-specific interstitial pneumonia, hypersensitivity pneumonia, latent systemic pneumonia (COP), sarcoidosis, and acute interstitial pneumonia. Interstitial lung disease (ILD) can be treated with drugs such as corticosteroids, antifibrotic drugs, pirfenidone, and nintedanib.

Market Segments

Global Interstitial Lung Disease Market, By Disease Type:

• Interstitial Pneumonia
• Idiopathic Pulmonary Fibrosis
• Nonspecific Interstitial Pneumonitis
• Hypersensitivity Pneumonitis
• Cryptogenic Organizing Pneumonia (COP)
• Sarcoidosis
• Acute Interstitial Pneumonitis

Global Interstitial Lung Disease Market, By Drug Type:

• Corticosteroids
• Anti-fibrotic Medication
• Pirfenidone
• Nintedanib

Key Players

• Boehringer Ingelheim
• Bellerophon Therapeutics
• Inc
• Bayer
• Fujirebio (Miraca)
• Philips
• Merck
• Siemens Healthineers

Scope of the Report

The research study analyzes the global Interstitial Lung Disease (ILD) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Interstitial Lung Disease (ILD) Market Report

1. What was the Interstitial Lung Disease (ILD) Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Interstitial Lung Disease (ILD) Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Interstitial Lung Disease (ILD) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.